Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
Status:
Unknown status
Trial end date:
2019-12-31
Target enrollment:
Participant gender:
Summary
This phase I clinical trial studies the side effects of selinexor in treating patients with
melanoma that cannot be removed by surgery. Drugs used in chemotherapy, such as selinexor,
may stop the growth of tumor cells, by stopping them from dividing.